Simphotek

Simphotek is a 3-employee software company headquartered in Newark, New Jersey. The company focuses on developing cutting-edge technology to revolutionize cancer treatment. Simphotek's core expertise lies in creating accurate simulations of light interactions within photo-activated materials. Simphotek provides critical light treatment planning information to physicians using a combination of laser light and light drugs to produce a photo-chemical reaction that destroys cancer cells. Their technology, known as Photodynamic Therapy (PDT), offers a significantly less toxic alternative to conventional cancer therapies and allows for repeated treatments as needed. Simphotek's patented simulation technology enables researchers, engineers, and product managers to analyze complex light-matter interactions, design optimized materials, and avoid costly physical testing. Simphotek believes that personalized cancer treatment using light, facilitated by their precise dosimetry, will make PDT a standard alternative cancer cure option accessible to all cancer facilities. For more information, visit simphotek.com.